Connection
Charles Dinarello to Hypoglycemic Agents
This is a "connection" page, showing publications Charles Dinarello has written about Hypoglycemic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.088 |
|
|
|
-
Cavelti-Weder C, Babians-Brunner A, Keller C, Stahel MA, Kurz-Levin M, Zayed H, Solinger AM, Mandrup-Poulsen T, Dinarello CA, Donath MY. Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care. 2012 Aug; 35(8):1654-62.
Score: 0.046
-
Dinarello CA. Blocking interleukin-1ß in acute and chronic autoinflammatory diseases. J Intern Med. 2011 Jan; 269(1):16-28.
Score: 0.042